Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Completed · Phase 1
Conditions studied: Invasive Candidiasis, Esophageal Candidiasis, Oropharyngeal Candidiasis, Candidemia
In brief
Infants and toddlers with fungal infections will receive 10 to 14 days of treatment with an antifungal drug. Safety and drug blood levels will be assessed
Key facts
- Study ID
- NCT00607763
- Run by
- Astellas Pharma Inc
- People needed
- 9
- Starts
- 2007-10-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2014-08-20
Who can join
Age: 0 and older, up to 2. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is ≥4 months to < 24 months
- Subject has suspected, proven or probable candidiasis, candidemia or other invasive candidiasis
- Subject has sufficient venous access to permit administration of study medication, collection of pharmacokinetic samples, and monitoring of laboratory safety variables
You may not qualify if…
- Subject has evidence of significant liver disease, as defined by aspartate transaminase (AST), alanine transaminase (ALT), bilirubin or alkaline phosphatase > 5 times the upper limit of normal (ULN)
- Subject has a concomitant medical condition that in the opinion of the investigator and/or medical monitor precludes enrollment into the study
- Subject has a history of anaphylaxis, hypersensitivity, or any serious reaction to the echinocandin class of antifungals
- Subject has received treatment with an echinocandin within one week prior to first dosing
- Subject status is unstable and subject is unlikely to complete all study required procedures
Where it is running
- Study site — Los Angeles, California, United States
- Study site — Orange, California, United States
- Study site — Louisville, Kentucky, United States
- Study site — Kansas City, Missouri, United States
- Study site — Dallas, Texas, United States
- Study site — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.